Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: Prevalence of and risk factors for diabetes mellitus in CKD in the Kidney Early Evaluation Program (KEEP)

American Journal of Kidney Diseases

Volumn 57, Issue 3 SUPPL. 2, 2011, Pages

  McFarlane, Samy I ^a   McCullough, Peter A ^b   Sowers, James R ^c   Soe, Kyaw ^a   Chen, Shu Cheng ^d   Li, Suying ^d   Vassalotti, Joseph A ^e,f   Stevens, Lesley A ^g   Salifu, Moro O ^a   Kurella Tamura, Manjula ^h   Bomback, Andrew S ⁱ   Norris, Keith C ^j   Collins, Allan J ^d,k   Bakris, George L ^l   Whaley Connell, Adam T ^c  

^a KINGS COUNTY HOSPITAL CENTER   (United States)

^b St John Providence Health System   (United States)

^c University of Missouri   (United States)

^d MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^e NATIONAL KIDNEY FOUNDATION   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g TUFTS MEDICAL CENTER   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^j CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^k UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^l UNIVERSITY OF CHICAGO   (United States)

more..

Author keywords

Chronic kidney disease; diabetes mellitus; estimated glomerular filtration rate

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION EQUATION; CONTROLLED STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY EARLY EVALUATION PROGRAM; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL HISTORY; MODIFICATION OF CIET IN RENAL DISEASE EQUATION; OBESITY; PREVALENCE; RISK FACTOR; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; COOPERATIVE BEHAVIOR; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; FOOD HABITS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; PROGRAM EVALUATION; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 79951860887     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.11.009     Document Type: Article

References (43)

1. Danaei G, Friedman AB, Oza S, Murray CJ, Ezzati M. Diabetes prevalence and diagnosis in US states: analysis of health surveys. Popul Health Metr. 2009;7:16. doi:10.1186/1478-7954-7-16.
2. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4-14.
3. Collins AJ, Foley RN, Gilbertson DT, Chen SC. The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis. Clin J Am Soc Nephrol. 2009;4(suppl 1):S5-S11.
4. Foley RN. Temporal trends in the burden of chronic kidney disease in the United States. Curr Opin Nephrol Hypertens. 2010; 19:273-277.
5. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999; 100:1134-1146. (Pubitemid 29416243)
6. McCullough PA, Li S, Jurkovitz CT, et al. CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis. 2008;51(suppl 2):S38-S45.
7. McFarlane SI, Banerji M, Sowers JR. Insulin resistance and cardiovascular disease. J Clin Endocrinol Metab. 2001;86:713-718. (Pubitemid 32207485)
8. Sowers JR, Lester MA. Diabetes and cardiovascular disease. Diabetes Care. 1999;22(suppl 3):C14-C20. (Pubitemid 29164912)
9. Salifu MO, Abbott KC, Aytug S, et al. New-onset diabetes after hemodialysis initiation: impact on survival. Am J Nephrol. 2010;31:239-246.
10. Whaley-Connell A, Pavey BS, McCullough PA, et al. Dysglycemia predicts cardiovascular and kidney disease in the Kidney Early Evaluation Program. J Clin Hypertens (Greenwich). 2010;12:51-58.
11. American Diabetes Association. Executive summary: American Diabetes Association. standards of medical care in diabetes - 2010. Diabetes Care. 2010;33(suppl 1):S4-S10.
12. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33(suppl 1):S11-S61.
13. The Diabetes Prevention Program Research Group. Strategies to identify adults at high risk for type 2 diabetes: the Diabetes Prevention Program. Diabetes Care. 2005;28:138-144.
14. Farag A, Karam J, Nicasio J, McFarlane SI. Prevention of type 2 diabetes: an update. Curr Diabetes Rep. 2007;7:200-207. (Pubitemid 46957283)
15. Chadban S. New-onset diabetes after transplantation - should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients. Nephrol Dial Transplant. 2008;23:1816-1818. (Pubitemid 351768173)
16. Iida S, Ishida H, Tokumoto T, et al. New-onset diabetes after transplantation in tacrolimus-treated, living kidney transplantation: long-term impact and utility of the pre-transplant OGTT. Int Urol Nephrol. 2010;42:935-945.
17. Luan FL, Langewisch E, Ojo A. Metabolic syndrome and new onset diabetes after transplantation in kidney transplant recipients. Clin Transplant. 2010;24:778-783.
18. Marrero D, Hernandez D, Tamajon LP, et al. Pre-transplant weight but not weight gain is associated with new-onset diabetes after transplantation: a multi-centre cohort Spanish study. NDT Plus. 2010;3:ii15-ii20.
19. Porrini E, Delgado P, Alvarez A, et al. The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation. Nephrol Dial Transplant. 2008;23:1436-1441. (Pubitemid 351767488)
20. Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247-254. (Pubitemid 46768608)
21. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150: 604-612.
22. NHANES. National Health and Nutrition Examination Survey III: body measurements (authropometry). 2008. http://www.cdc.gov/nchs/data/nhanes/nhanes3/ cdrom/nchs/manuals/anthro.pdf . Accessed August 24, 2010.
23. McCullough PA, Verrill TA. Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease. Postgrad Med. 2010;122:25-34.
24. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63:225-232. (Pubitemid 35463925)
25. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
26. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23(suppl 2):B21-B29. (Pubitemid 30185774)
27. Eckel RH. Diabetic dyslipidemia and cardiovascular risk. Curr Diabetes Rep. 2008;8:421-423.
28. Wannamethee SG, Shaper AG, Perry IJ. Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care. 2001;24:1590-1595. (Pubitemid 33716454)
29. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298:2654-2664. (Pubitemid 350254957)
30. Rimm EB, Manson JE, Stampfer MJ, et al. Cigarette smoking and the risk of diabetes in women. Am J Public Health. 1993;83:211-214. (Pubitemid 23046478)
31. Yeh HC, Duncan BB, Schmidt MI, Wang NY, Brancati FL. Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2010;152:10-17.
32. McFarlane SI, Jacober SJ, Winer N, et al. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care. 2002;25: 718-723. (Pubitemid 41071193)
33. Centers for Disease Control and Prevention. Cigarette smoking among adults and trends in smoking cessation - United States, 2008. MMWR Morbid Mortal Wkly Rep. 2009;58:1227-1232.
34. Seidell JC. Obesity, insulin resistance and diabetes - a worldwide epidemic. Br J Nutr. 2000;83(suppl 1):S5-S8. (Pubitemid 30319075)
35. Feller S, Boeing H, Pischon T. Body mass index, waist circumference, and the risk of type 2 diabetes mellitus: implications for routine clinical practice. Dtsch Arztebl Int. 2010;107:470-476.
36. Janiszewski PM, Janssen I, Ross R. Does waist circumference predict diabetes and cardiovascular disease beyond commonly evaluated cardiometabolic risk factors? Diabetes Care. 2007;30:3105-3109. (Pubitemid 350255257)
37. Klein S, Allison DB, Heymsfield SB, et al.Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Obesity (Silver Spring). 2007;15:1061-1067. (Pubitemid 46932459)
38. Lopatynski J, Mardarowicz G, Szczesniak G. A comparative evaluation of waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index as indicators of impaired glucose tolerance and as risk factors for type-2 diabetes mellitus. Ann Univ Mariae Curie Sklodowska Med. 2003;58:413-419.
39. Castro JP, El-Atat FA, McFarlane SI, Aneja A, Sowers JR. Cardiometabolic syndrome: pathophysiology and treatment. Curr Hypertens Rep. 2003;5:393-401. (Pubitemid 38898963)
40. El-Atat FA, Stas SN, McFarlane SI, Sowers JR. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol. 2004;15:2816-2827. (Pubitemid 41103390)
41. Shah S, Iqbal M, Karam J, Salifu M, McFarlane SI. Oxidative stress, glucose metabolism, and the prevention of type 2 diabetes: pathophysiological insights. Antioxid Redox Signal. 2007;9:911-929. (Pubitemid 46919593)
42. Hanai K, Babazono T, Nyumura I, et al. Involvement of visceral fat in the pathogenesis of albuminuria in patients with type 2 diabetes with early stage of nephropathy. Clin Exp Nephrol. 2010;14:132-136.
43. Suliman ME, Yilmaz MI, Carrero JJ, et al. Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. Clin J Am Soc Nephrol. 2008;3:976-985.